Correction to : Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis
| Errataetall: |
ErratumFor: Target Oncol. 2021 May;16(3):401-410. - PMID 33646487 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Targeted oncology - 16(2021), 3 vom: 18. Mai, Seite 411-412 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bang, Yeonghak [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.05.2021 published: Print ErratumFor: Target Oncol. 2021 May;16(3):401-410. - PMID 33646487 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s11523-021-00808-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322951909 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322951909 | ||
| 003 | DE-627 | ||
| 005 | 20231225183128.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11523-021-00808-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1076.xml |
| 035 | |a (DE-627)NLM322951909 | ||
| 035 | |a (NLM)33738697 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bang, Yeonghak |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.05.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Target Oncol. 2021 May;16(3):401-410. - PMID 33646487 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Yoo, Changhoon |e verfasserin |4 aut | |
| 700 | 1 | |a Lonardi, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Hyung-Don |e verfasserin |4 aut | |
| 700 | 1 | |a Vivaldi, Caterina |e verfasserin |4 aut | |
| 700 | 1 | |a Rimini, Margherita |e verfasserin |4 aut | |
| 700 | 1 | |a Frassineti, Giovanni Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Sook Ryun |e verfasserin |4 aut | |
| 700 | 1 | |a Rizzato, Mario Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Ryu, Min-Hee |e verfasserin |4 aut | |
| 700 | 1 | |a Salani, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Rapposelli, Ilario Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Ryoo, Baek-Yeol |e verfasserin |4 aut | |
| 700 | 1 | |a Zagonel, Vittorina |e verfasserin |4 aut | |
| 700 | 1 | |a Massa, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Valgiusti, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Burgio, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Scartozzi, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Cascinu, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Casadei-Gardini, Andrea |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Targeted oncology |d 2009 |g 16(2021), 3 vom: 18. Mai, Seite 411-412 |w (DE-627)NLM187616825 |x 1776-260X |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g number:3 |g day:18 |g month:05 |g pages:411-412 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11523-021-00808-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2021 |e 3 |b 18 |c 05 |h 411-412 | ||